<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04546295</url>
  </required_header>
  <id_info>
    <org_study_id>Brushlink</org_study_id>
    <nct_id>NCT04546295</nct_id>
  </id_info>
  <brief_title>Effect of Smartphone Application on Reducing Localized Inflammation in Periodontal Maintenance Patients</brief_title>
  <official_title>Effect of Smartphone Application on Reducing Localized Inflammation in Periodontal Maintenance Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intent of this study is to determine the effect of a smartphone application used in&#xD;
      conjunction with interproximal cleaning on localized, inflamed periodontal pockets of&#xD;
      periodontal maintenance patients. The hypothesis to be tested is that the use of the&#xD;
      smartphone application will decrease clinical parameters of inflammation (probing depths,&#xD;
      bleeding on probing) as well as the pro-inflammatory biomarker (IL-1B) as determined in&#xD;
      gingival crevicular fluid sampling.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Numerous studies have shown that high quality home care (oral hygiene) is key in achieving&#xD;
      stability in periodontal patients. Any technology that can potentially improve a patient's&#xD;
      home care could be instrumental in decreasing periodontal inflammation and therefore could&#xD;
      improve a patient's overall oral health.&#xD;
&#xD;
      The clinical phase of this 6-week, randomized, single-masked, interventional clinical trial&#xD;
      will include randomization of 66 individuals regularly attending the University of Nebraska&#xD;
      Medical Center College of Dentistry for periodontal maintenance therapy (PMT). The inclusion&#xD;
      criteria for the study will include patients between the ages of 40-85 years, a periodontal&#xD;
      diagnosis of moderate-advanced chronic periodontitis, one 5-7 mm interproximal probing depth&#xD;
      (test site) with 2 mm between inferior border of contact and gingival margin, overall good&#xD;
      systemic health, history of regular PMT, and ownership of a smartphone device. Exclusion&#xD;
      criteria will eliminate patients with systemic diseases that significantly affect periodontal&#xD;
      inflammation and bone turnover, and surgical periodontal therapy within the past year.&#xD;
      Following informed consent, patients will be randomly assigned to one of three groups (22&#xD;
      patients per group): one group will receive instruction in the use of an interproximal&#xD;
      cleaner with the Brushlink® app at the test site (BL), one group will receive instruction in&#xD;
      the use of a water-flosser at the test site, and one group will receive instruction in the&#xD;
      use of an interproximal cleaner (IP) alone at the test site. Groups will be randomized by&#xD;
      gender and smoking status by a clinician not involved with clinical measurements.&#xD;
      Measurements of plaque index (PI), gingival index (GI), probing depth (PD), recession and&#xD;
      gingival crevicular fluid (GCF) samples will obtained at baseline and 6 weeks by one of three&#xD;
      calibrated clinicians (AK, RR, LS). During data collection, supragingival plaque will be&#xD;
      removed (and recorded), then an absorbent paper strip will be inserted into the facial and&#xD;
      lingual sulci of the test site for 30 seconds for collection of GCF. Following data&#xD;
      collection, patients will be instructed to use either the interproximal brush + Brushlink®,&#xD;
      water-flosser, or interproximal cleaner alone at the test site once daily for 6 weeks.&#xD;
      Patients will return at 6 weeks for clinical measurements and GCF sampling. The GCF samples&#xD;
      will be analyzed via ELISA for the inflammatory biomarker, IL-1B. Clinical data will be&#xD;
      submitted to statistical analysis to determine differences between groups with p-values &lt;/=&#xD;
      0.05 being considered statistically significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Attachment Level</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>IL-1 levels</measure>
    <time_frame>6 weeks</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Periodontal Inflammation</condition>
  <arm_group>
    <arm_group_label>Brushlink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Water-flosser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Interproximal Brush</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brushlink application</intervention_name>
    <description>Brushlink application + Interproximal brush</description>
    <arm_group_label>Brushlink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water-flosser</intervention_name>
    <description>Water-flosser</description>
    <arm_group_label>Water-flosser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interproximal brush</intervention_name>
    <description>Interproximal brush alone</description>
    <arm_group_label>Brushlink</arm_group_label>
    <arm_group_label>Interproximal Brush</arm_group_label>
    <arm_group_label>Water-flosser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  a periodontal diagnosis of moderate-advanced chronic periodontitis,&#xD;
&#xD;
          -  one 5-7 mm interproximal probing depth (test site) with 2 mm between inferior border&#xD;
             of contact and gingival margin&#xD;
&#xD;
          -  overall good systemic health&#xD;
&#xD;
          -  history of regular PMT, and ownership of a smartphone device&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  systemic diseases that significantly affect periodontal inflammation and bone turnover&#xD;
&#xD;
          -  surgical periodontal therapy within the past year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amy Killeen, DDS</last_name>
    <phone>402-472-7848</phone>
    <email>akilleen@unmc.edu</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>September 4, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2020</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Amy C. Killeen, DDS, MS</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

